A new study finds that more than 200 human-targeted, non-antibiotic drugs inhibit the growth of bacterial species that make up part of the human microbiome.
Lacing insect food with microbes encoding double-stranded RNAs can suppress insect gene expression.
June 1, 2016|
© GEORGE RETSECK
RNA interference (RNAi)—the use of a double-stranded RNA (dsRNA) to trigger the destruction of a corresponding gene’s messenger RNA—is a popular method for ascertaining gene function. But for entomologists there’s a problem. “We have a major challenge with insects in terms of getting an effective and efficient delivery mechanism,” says Owain Edwards of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Canberra, Australia.
Current dsRNA delivery methods include ingestion and injection, but the primary issue with both of these is the transient availability of dsRNA once inside the insects—thus necessitating a continuous supply. Injection can also cause trauma, especially to smaller insects.
To prolong RNAi’s effects in insects and to develop a gentler mode of delivery, Paul Dyson, Miranda Whitten, and colleagues at Swansea University in the U.K. enlisted the help of the animals’ own symbiotic gut bacteria. They engineered a microbial species that resides in western flower thrips (Frankliniella occidentalis), a widespread crop pest, to express custom dsRNAs, then mixed the bacteria with the insect’s food.
Once the microbes colonized the hosts’ guts, the dsRNA released from the bacteria suppressed a gene essential for thrip survival, and many insects died. The researchers used the same approach to successfully block a key fecundity gene in a major Chagas disease vector, Rhodnius prolixus, and the number of offspring subsequently declined. In the latter example, the bacteria—different from those deployed in thrips—stably expressed the dsRNA, persisted in the insects’ guts for many months, and could suppress the target gene in other R. prolixus members by spreading to individuals via coprophagy, eating one another’s poop.
Such a sustained RNAi effect could be valuable for insect-control strategies, says Dyson. Angela Douglas of Cornell University says the technique “enormously expands the potential for RNAi in insects.” (Proc R Soc B, doi:10.1098/rspb.2016.0042, 2016)
|dsRNA DELIVERY TECHNIQUE||HOW IT WORKS||ADVANTAGES||LIMITATIONS|
|Ingestion||The dsRNA of interest is mixed with the insect’s food, and once in the gut it is absorbed into the tissues.||No genetic engineering of vector bacteria is required.||RNAi effect ceases without a constant supply of the dsRNA.|
|Genetically engineered symbiotic gut bacteria||A commensal bacterium’s genome is engineered to express a dsRNA of interest. The microbes are then introduced to the insect’s gut via food. The bacteria reside in the gut long-term, continuously supplying dsRNA.||
If bacteria stably express the dsRNA, then the RNAi effect lasts as long as the bacteria are present in gut.
Depending on the insect and bacterial species, horizontal transfer of engineered bacteria may be possible, thus targeting many insects at once.
|A commensal bacterium amenable to laboratory culture and genetic manipulation may not be available for a particular insect species of interest.|